Grifols ADRs Tumble After Brookfield Reportedly Backs Away from Takeover Bid
Grifols' American depositary receipts slumped following a report that Brookfield Asset Management plans to abandon its acquisition of the Spanish pharmaceuticals company. The stock was down 18% at $7.14 in premarket trading. Shares had already fallen nearly 25% year-to-date when the market closed Tuesday.
For Spain’s billionaire Grifols family, which turned a blood-collection business into one of the world’s largest medical ...
Is Brookfield Asset Management (TSX:BAM) a solid buy for its dividend yield, especially given the recent surge in its stock ...
Raymond James Trust N.A. reduced its holdings in Brookfield Asset Management Ltd. (NYSE:BAM – Free Report) (TSE:BAM.A) by 2.7 ...
Brookfield Wealth Solutions rebranded and changed the ticker from BNRE to BNT. BNT acquired American Equity Investment Life.
Shares of Brookfield Asset Management Ltd. Cl A BAM rallied 1.19% to C$78.42 Monday, in what proved to be an otherwise ...
Brookfield Asset Management Ltd. (NYSE:BAM – Get Free Report) (TSE:BAM.A) has received a consensus rating of “Hold” ...
Brookfield Asset Management's management aims to double operational metrics in five years. Read why BAM is a low-maintenance ...
3hon MSN
The companies have just set the price for the majority stakes Brookfield owns in malls Patio Paulista and Patio Higienopolis, aiming to finalize a deal by the end of December, sources said this week ...
Brookfield Asset Management Ltd. abandonó los planes de adquirir Grifols SA, poniendo fin a meses de negociaciones para ...
BIP currently has four series of Preferred Units outstanding and that trade on the TSX. Under BIP’s normal course issuer bid, BIP is authorized to repurchase up to 10% of the total public float of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback